Group 1 - Sam Altman, CEO of OpenAI, has successfully raised $252 million (approximately 1.8 billion RMB) in seed funding for Merge Labs, a brain-computer interface company, significantly exceeding the early funding scale of most neurotechnology companies [2][3] - Merge Labs is focusing on a non-invasive technology approach, utilizing ultrasound and other methods to send and receive information without implanting electrodes in the brain, contrasting sharply with Elon Musk's invasive strategy with Neuralink [2][3] - The competition between Altman and Musk in the brain-computer interface sector represents a broader trend in the global brain-computer interface industry, which is experiencing rapid growth due to technological breakthroughs, supportive policies, and increased capital investment [6][9] Group 2 - OpenAI is the largest investor in Merge Labs' recent funding round, indicating a potential integration of OpenAI's core algorithms with brain-computer interface technology, which distinguishes Merge Labs from other companies in the field [4] - Merge Labs aims to connect biological intelligence with artificial intelligence to maximize human capabilities and experiences, developing a new paradigm of brain-computer interfaces for high-bandwidth interaction with advanced AI [4] - The global brain-computer interface market is projected to grow from approximately $2.62 billion in 2024 to $12.4 billion by 2034, with China's market expected to increase from 3.2 billion RMB in 2024 to 5.58 billion RMB by 2027, reflecting a compound annual growth rate of about 20% [6]
融资18亿!奥特曼杀入马斯克脑机地盘
Sou Hu Cai Jing·2026-01-16 10:51